Related Experiment Video
Updated: Jul 4, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Recent progress in the management of retroperitoneal sarcoma
R Cheifetz1, C N Catton, R Kandel
1Department of Surgical Oncology Mount Sinai Hospital and Princess Margaret Hospital University of Toronto Ontario Toronto Canada.
Sarcoma
|June 4, 2008
Summary
Retroperitoneal sarcomas (RPS) are rare, often late-presenting tumors with poor prognoses. While surgery is primary, adjuvant therapies like radiation show potential but require further study to improve patient outcomes.
Area of Science:
- Surgical Oncology
- Radiation Oncology
- Medical Oncology
Background:
- Retroperitoneal sarcomas (RPS) are rare malignancies with a high rate of recurrence and poor prognosis.
- Late presentation is common, complicating treatment and outcomes.
- Current management often involves surgery, but recurrence rates remain high.
Purpose of the Study:
- To review the presentation and prognosis of retroperitoneal sarcomas.
- To evaluate the efficacy of novel treatment strategies compared to conventional management.
- To discuss challenges in RPS treatment and explore alternative approaches.
Main Methods:
- A Medline search identified English literature on adult RPS management published since 1980.
- Included retrospective and prospective studies analyzing RPS separately.
- Extracted data on investigation, presentation, prognostic factors, treatment, and outcomes from 31 eligible reports.
Main Results:
- Surgical resection is the primary treatment for RPS, but most patients experience relapse within 5 years.
- Adjuvant radiation therapy may offer improved outcomes, though definitive evidence from further trials is needed.
- The study discusses reasons for conventional treatment failures and presents alternative strategies.
Conclusions:
- Despite surgical resection, RPS recurrence is frequent, necessitating improved therapeutic strategies.
- Adjuvant radiation shows promise but requires further investigation to confirm its benefit.
- Exploring novel treatment approaches is crucial to overcome limitations in current RPS management.
